semaglutide patent india As the patents on semaglutide, a popular diabetes and anti-obesity drug that earned its Danish maker Novo Nordisk nearly USD 30 billion in FY25 alone, expire in nearly 100 countries next year Semaglutide Patent Expiry India: ₹5000

Long-acting or combined formulations Long-acting formulations have been developed to release drugs steadily over extended periods, ranging from weeks to years

A 2023 SELECT trial determined that patients with pre-existing cardiovascular disease who used Wegovy over 39.8 months experienced the following events, compared to patients given a placebo

Adverse events were mostly mild-to-moderate gastrointestinal symptoms, consistent with other incretin-based therapies

MK: Investigation, Writing original draft

You can start investing in US stocks and ETFs with $1, then align your next steps with your goals and risk profile

How Long Should You Maintain Semaglutide Treatment for Effective Weight Loss?